Ulcerative Colitis articles & resources on Made-in-China.com

The FDA Won't Let 23andme Sell Its Personal Genomic Service Tests

Jan 12, 2015

The FDA won’t let 23andMe sell its Personal Genomic Service tests to consumers in the United States, but that hasn’t stopped the company from selling its customers’ anonymous information to other companies for research. ...

Tags: Genomic Service tests, anonymous information, Health

The FDA Has Approved a Non-Invasive Test for Colorectal Cancer

Aug 15, 2014

People over 50, rejoice! The FDA has approved a non-invasive test for colorectal cancer, and it may not take years to obtain. Mayo Clinic gastroenterologist David Ahlquist co-invented the test, Cologuard, which detects the presence of ...

Tags: FDA, Health, Medicine

Potential Breakthrough Drug Might Come From Big Tobacco

Aug 1, 2014

Big Tobacco, almost unbelievably, is lending a hand in the creation of a potential breakthrough drug, a new class of drugs that could dull grave psychiatric disorders, improve attention of ADHD afflicted children, repel Alzheimer's onset, ...

Tags: Agriculture, Tobacco, Ecigarette

Altheus Therapeutics Has Completed Enrollment for ZA201

Jan 13, 2014

Altheus Therapeutics, Inc., announced that it has completed enrollment for ZA201, a 6-week, double-blind, active-controlled Phase 2 clinical trial of the efficacy and safety of Zoenasa® Rectal Gel in approximately 120 adult patients ...

Tags: Altheus Therapeutics, enrollment, ZA201, Zoenasa®Rectal Gel

Chances Are Composition of Your Gut Bacteria Undergo a Big Change When Changes in Diet

Dec 27, 2013

If you were to switch from vegetarianism to meat-eating, or vice-versa, chances are the composition of your gut bacteria would also undergo a big change, a new study suggests. The research, published Dec. 11 in the journal Nature, showed ...

Tags: gut bacteria, change in diet, animal-based diet, plant-based diet

Vedolizumab Is Under Review for The Treatment of Adults

Dec 27, 2013

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food & Drug Administration (FDA) has extended the Prescription Drug User ...

Tags: Takeda Pharmaceutical Company Limited, Prescription Drug User Fee Act

Kraft Foods and Dow Chemical Company Have All Had Issues to Address

Nov 27, 2013

A look back through our archives sees that DuPont, Dr Pepper, Post Holdings and Ralcorp Holdings, Kraft Foods and Dow Chemical Company have all had issues to address. General Mills is working to undo the impact of poor waste disposal more ...

Tags: Changing, environmental, issue, food, firm

Here Are Five Effective Essential Oils Can Be Used to Treat Chronic Digestive Distress

Nov 21, 2013

If you suffer from chronic indigestion, constipation, upset stomach or some other persistent digestive disorder that you are having trouble remedying, essential oils just might be your answer for finding lasting relief. Here are five of the ...

Tags: 5, unbeatable, essential oil, chronic, digestive, distress

Second Genome Has Signed a Microbiome Drug Discovery Deal with Janssen Biotech

Jun 8, 2013

Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the human gut to treat ulcerative colitis. Under the collaboration, Janssen ...

Tags: Microbiome Drug, Medicine

Trino Therapeutics Received More Than $12m Funding to Advance Ulcerative Colitis Drug

May 29, 2013

Drug discovery and early drug development company Trino Therapeutics has received more than €9m ($12m) funding from investors, including Fountain Healthcare Partners and founding investor, the Wellcome Trust, to advance the development ...

Tags: Trino, Colitis Drug

Janssen Biotech Has Announced The FDA Approval of Simponi (Golimumab) to Treat Moderately

May 17, 2013

Janssen Biotech has announced the FDA approval of Simponi (golimumab) to treat moderately to severely active ulcerative colitis (UC) in adult patients with corticosteroid dependence or an inadequate response to or failed to tolerate oral ...

Tags: FDA, Janssen Biotech

IBD has Been Launched Expanded Testing Profile by Labcorp

Apr 2, 2013

Laboratory Corporation of America (LabCorp) has launched an expanded testing menu to help clinicians diagnose, treat and monitor the course of inflammatory bowel disease (IBD). The menu comprises IBD Expanded Profile that includes ...

Tags: Labcorp, Expanded Testing Profile, Inflammatory Bowel Disease

Takeda Pharmaceutical Company Has Submitted MAA Seeking Approval From The EMA

Mar 11, 2013

Takeda Pharmaceutical Company has submitted marketing authorisation application (MAA) seeking approval from the European Medicines Agency (EMA) for its investigational, gut-selective humanized monoclonal antibody for the treatment of adults ...

Tags: Takeda, IBD Disease Drug, MAA, EMA

Santarus Has Announced The Commercial Launch of Ulcerative Colitis Therapy

Feb 19, 2013

Specialty biopharmaceutical company Santarus has announced the commercial launch of ulcerative colitis therapy, Uceris (budesonide) extended release tablets. Uceris that contains a locally acting glucocorticosteroid, budesonide, in a ...

Tags: Santarus, Uceris, ulcerative colitis therapy

The US FDA Has Approved Warner Chilcott's 400mg Mesalamine Product

Feb 13, 2013

The US FDA has approved Warner Chilcott's 400mg mesalamine product as new ulcerative colitis therapy, to be marketed as Delzicol. Warner expects to commercially launch Delzicol in March 2013. Delzicol delayed-release capsules are ...

Tags: FDA, Warner Delzicol, ulcerative colitis therapy

Ulcerative Colitis

Related Products